CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
46.64
0.09%
Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.18
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026235 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026235%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.004012 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004012%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Sanofi SA ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 46.69
Open* 46.44
1-Year Change* 2.61%
Day's Range* 46.28 - 46.8
52 wk Range 42.63-57.82
Average Volume (10 days) 1.90M
Average Volume (3 months) 42.57M
Market Cap 118.06B
P/E Ratio 11.83
Shares Outstanding 1.25B
Revenue 49.85B
EPS 3.94
Dividend (Yield %) 4.08182
Beta 0.59
Next Earnings Date Feb 1, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Nov 30, 2023 46.69 0.63 1.37% 46.06 46.71 45.84
Nov 29, 2023 46.38 -0.44 -0.94% 46.82 46.88 46.33
Nov 28, 2023 46.93 0.03 0.06% 46.90 47.29 46.85
Nov 27, 2023 47.60 0.07 0.15% 47.53 47.63 47.19
Nov 24, 2023 47.13 0.13 0.28% 47.00 47.24 46.97
Nov 22, 2023 46.37 0.07 0.15% 46.30 46.43 46.02
Nov 21, 2023 46.52 0.03 0.06% 46.49 46.80 46.42
Nov 20, 2023 46.43 -0.07 -0.15% 46.50 46.88 46.43
Nov 17, 2023 46.94 0.26 0.56% 46.68 46.95 46.45
Nov 16, 2023 46.27 0.32 0.70% 45.95 46.30 45.85
Nov 15, 2023 45.36 0.08 0.18% 45.28 46.05 45.05
Nov 14, 2023 45.66 0.05 0.11% 45.61 46.00 45.50
Nov 13, 2023 45.44 0.15 0.33% 45.29 45.60 45.07
Nov 10, 2023 45.86 -0.19 -0.41% 46.05 46.06 44.97
Nov 9, 2023 45.43 -0.71 -1.54% 46.14 46.15 45.31
Nov 8, 2023 45.71 -0.05 -0.11% 45.76 46.18 45.56
Nov 7, 2023 45.20 0.17 0.38% 45.03 45.36 44.94
Nov 6, 2023 45.17 -0.44 -0.96% 45.61 45.74 45.03
Nov 3, 2023 45.74 0.23 0.51% 45.51 46.09 45.15
Nov 2, 2023 46.45 -0.45 -0.96% 46.90 47.03 46.11

Sanofi Adr Rep 1 1/2 Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 45389 39175 37369 37631 35677
Revenue 45389 39175 37369 37631 35677
Cost of Revenue, Total 13695 12255 12159 11979 11435
Gross Profit 31694 26920 25210 25652 24242
Total Operating Expense 34733 31049 23256 34580 31001
Selling/General/Admin. Expenses, Total 10410 9457 9304 9777 9772
Research & Development 6705 5689 5528 6017 5890
Depreciation / Amortization 2140 1681 1774 2262 2264
Unusual Expense (Income) -581 235 777 3966 1696
Other Operating Expenses, Total 2391 1728 1220 817 61
Operating Income 10656 8126 14113 3051 4676
Interest Income (Expense), Net Non-Operating -167 -289 -263 -210 -273
Other, Net -67 -39 -72 -89 2
Net Income Before Taxes 10422 7798 13778 2752 4405
Net Income After Taxes 8416 6240 11971 2631 3924
Minority Interest -113 -56 -36 -31 -104
Equity In Affiliates 68 39 359 255 499
Net Income Before Extra. Items 8371 6223 12294 2855 4319
Total Extraordinary Items 0 0 -101 -13
Net Income 8371 6223 12294 2754 4306
Income Available to Common Excl. Extra. Items 8371 6223 12294 2855 4319
Income Available to Common Incl. Extra. Items 8371 6223 12294 2754 4306
Diluted Net Income 8371 6223 12294 2754 4306
Diluted Weighted Average Shares 1256.9 1257.9 1260.1 1257.1 1255.2
Diluted EPS Excluding Extraordinary Items 6.66004 4.94713 9.75637 2.2711 3.44089
Dividends per Share - Common Stock Primary Issue 3.56 3.31263 3.2 3.15 3.07
Diluted Normalized EPS 5.79655 5.09663 10.2921 5.28727 4.64452
Interest Expense (Income) - Net Operating -27 4 -7506 -238 -117
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 21545 10863 24594 13138 20795
Revenue 21545 10863 24594 13138 20795
Cost of Revenue, Total 6347 3079 7565 3831 6130
Gross Profit 15198 7784 17029 9307 14665
Total Operating Expense 17223 8400 17767 10414 16966
Selling/General/Admin. Expenses, Total 5182 2607 5539 2644 4953
Research & Development 3193 1563 3559 1736 3147
Depreciation / Amortization 1035 489 1143 460 910
Unusual Expense (Income) 635 343 231 1955 1021
Other Operating Expenses, Total 805 304 -226 -180 788
Operating Income 4322 2463 6827 2724 3829
Interest Income (Expense), Net Non-Operating 4 -7 -62 -51 -135
Net Income Before Taxes 4238 2456 6748 2673 3674
Net Income After Taxes 3508 1997 5237 2072 3179
Minority Interest -26 -14 -60 -3 -53
Equity In Affiliates -52 12 10 7 58
Net Income Before Extra. Items 3430 1995 5187 2076 3184
Net Income 3430 1995 5187 2076 3184
Income Available to Common Excl. Extra. Items 3430 1995 5187 2076 3184
Income Available to Common Incl. Extra. Items 3430 1995 5187 2076 3184
Diluted Net Income 3430 1995 5187 2076 3184
Diluted Weighted Average Shares 1254.5 1249.3 1258.5 1253.5 1255.3
Diluted EPS Excluding Extraordinary Items 2.73416 1.59689 4.12157 1.65616 2.53645
Dividends per Share - Common Stock Primary Issue 0 0 3.56 0 0
Diluted Normalized EPS 3.15315 1.82014 4.26402 2.86513 3.24021
Interest Expense (Income) - Net Operating 26 15 -44 -32 17
Other, Net -88 -17 -20
Total Extraordinary Items
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 34026 30564 33703 28611 24579
Cash and Short Term Investments 13400 11152 14815 9853 7124
Cash 1385 1358 1144 701 661
Cash & Equivalents 11351 8740 12771 8726 6264
Short Term Investments 664 1054 900 426 199
Total Receivables, Net 10746 9787 9953 10083 9345
Accounts Receivable - Trade, Net 8424 7568 7491 7937 7260
Total Inventory 8960 8715 8352 7994 7477
Prepaid Expenses 714 615 525 493 469
Other Current Assets, Total 206 295 58 188 164
Total Assets 126722 120242 114413 112630 111408
Property/Plant/Equipment, Total - Net 11684 11976 10563 11017 9651
Property/Plant/Equipment, Total - Gross 26796 27555 24880 25151 22697
Accumulated Depreciation, Total -15112 -15579 -14317 -14134 -13046
Goodwill, Net 49892 48056 44364 44519 44235
Intangibles, Net 21640 21407 18341 16509 21889
Long Term Investments 2765 2425 2129 5303 5550
Note Receivable - Long Term 452 485 537 521 746
Other Long Term Assets, Total 6263 5329 4776 6150 4758
Total Current Liabilities 23964 21295 19248 20381 17376
Accounts Payable 6813 6180 5295 5313 5041
Accrued Expenses 2158 2126 2042 1978 1989
Notes Payable/Short Term Debt 168 189 285 305 249
Current Port. of LT Debt/Capital Leases 4287 3263 2714 4508 2364
Other Current Liabilities, Total 10538 9537 8912 8277 7733
Total Liabilities 51938 51561 51307 53574 52532
Total Long Term Debt 16761 18962 20676 21118 22071
Long Term Debt 14857 17123 19745 20131 22053
Capital Lease Obligations 1904 1839 931 987 18
Deferred Income Tax 1841 1617 1770 2294 3414
Minority Interest 368 350 146 174 159
Other Liabilities, Total 9004 9337 9467 9607 9512
Total Equity 74784 68681 63106 59056 58876
Common Stock 2522 2527 2518 2508 2495
Additional Paid-In Capital 66859 63545 60511 52049 53106
Treasury Stock - Common -706 -939 -705 -9 -153
Other Equity, Total 6109 3548 782 4508 3428
Total Liabilities & Shareholders’ Equity 126722 120242 114413 112630 111408
Total Common Shares Outstanding 1252.64 1252.54 1250.69 1253.83 1245.45
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 29976 34026
Cash and Short Term Investments 7993 12736
Cash & Equivalents 7993 12736
Total Receivables, Net 8642 8798
Accounts Receivable - Trade, Net 8289 8424
Total Inventory 9970 8960
Other Current Assets, Total 3371 3532
Total Assets 125353 126722
Property/Plant/Equipment, Total - Net 11527 11684
Goodwill, Net 49243 49892
Intangibles, Net 24590 21640
Long Term Investments 2550 2765
Note Receivable - Long Term 447 452
Other Long Term Assets, Total 7020 6263
Total Current Liabilities 24760 23964
Accounts Payable 7365 6813
Notes Payable/Short Term Debt 133 168
Current Port. of LT Debt/Capital Leases 4780 4287
Other Current Liabilities, Total 12482 12696
Total Liabilities 52724 51938
Total Long Term Debt 16080 16761
Long Term Debt 14241 14857
Capital Lease Obligations 1839 1904
Deferred Income Tax 1950 1841
Minority Interest 318 368
Other Liabilities, Total 9616 9004
Total Equity 72629 74784
Common Stock 2525 2522
Additional Paid-In Capital 140 66859
Retained Earnings (Accumulated Deficit) 65694
Treasury Stock - Common -957 -706
Other Equity, Total 5227 6109
Total Liabilities & Shareholders’ Equity 125353 126722
Total Common Shares Outstanding 1251.49 1252.64
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 8371 6223 12294 2754 4306
Cash From Operating Activities 10526 10522 7418 7715 5547
Cash From Operating Activities 3420 3351 3671 7445 4279
Deferred Taxes -578 -356 -221 -1772 -727
Non-Cash Items 20 -105 -8001 -293 -1031
Cash Taxes Paid 2452 1280 2051 1695 2058
Cash Interest Paid 380 334 315 379 412
Changes in Working Capital -707 1409 -325 -419 -1280
Cash From Investing Activities -2075 -7298 3619 -1029 -12872
Capital Expenditures -2201 -2043 -2083 -1787 -1977
Other Investing Cash Flow Items, Total 126 -5255 5702 758 -10895
Cash From Financing Activities -5821 -7056 -6485 -4193 3934
Financing Cash Flow Items -99 -48 -44 -21 -91
Total Cash Dividends Paid -4168 -4008 -3937 -3834 -3773
Issuance (Retirement) of Stock, Net -309 -196 -619 153 -924
Issuance (Retirement) of Debt, Net -1245 -2804 -1885 -491 8722
Foreign Exchange Effects 8 15 -64 9 1
Net Change in Cash 2638 -3817 4488 2502 -3390
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 8371 3184
Cash From Operating Activities 10526 3825
Cash From Operating Activities 3420 1820
Deferred Taxes -578 -404
Non-Cash Items 20 267
Cash Taxes Paid 2452 927
Cash Interest Paid 380 162
Changes in Working Capital -707 -1042
Cash From Investing Activities -2075 -1459
Capital Expenditures -2201 -974
Other Investing Cash Flow Items, Total 126 -485
Cash From Financing Activities -5821 -5605
Financing Cash Flow Items -99 -69
Total Cash Dividends Paid -4168 -4168
Issuance (Retirement) of Stock, Net -309 -320
Issuance (Retirement) of Debt, Net -1245 -1048
Foreign Exchange Effects 8 40
Net Change in Cash 2638 -3199
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Dodge & Cox Investment Advisor/Hedge Fund 3.1884 80500374 -2016952 2023-06-30 LOW
Fidelity Management & Research Company LLC Investment Advisor 0.7738 19536035 -666346 2023-06-30 LOW
Boston Partners Investment Advisor/Hedge Fund 0.5194 13114702 -4831241 2023-06-30 LOW
Fisher Investments Investment Advisor/Hedge Fund 0.5132 12956823 -402706 2023-06-30 LOW
Managed Account Advisors LLC Investment Advisor 0.2902 7328135 70778 2023-06-30 LOW
Invesco Advisers, Inc. Investment Advisor 0.2426 6125523 329525 2023-06-30 LOW
BlackRock Investment Management, LLC Investment Advisor/Hedge Fund 0.22 5554305 -366015 2023-06-30 LOW
Camber Capital Management LP Hedge Fund 0.1584 4000000 -1500000 2023-06-30 MED
Parametric Portfolio Associates LLC Investment Advisor 0.1413 3567583 91095 2023-06-30 LOW
Fidelity Institutional Asset Management Investment Advisor 0.1273 3213122 133302 2023-06-30 LOW
BofA Global Research (US) Research Firm 0.1233 3112755 -256827 2023-06-30 LOW
Federated Hermes Investment Counseling Investment Advisor/Hedge Fund 0.1017 2568436 466805 2023-06-30 MED
Hotchkis and Wiley Capital Management, LLC Investment Advisor 0.0935 2361025 -12900 2023-06-30 LOW
Wells Fargo Advisors Research Firm 0.0911 2299130 185816 2023-06-30 LOW
Envestnet Asset Management, Inc. Investment Advisor 0.0866 2187147 804620 2023-06-30 LOW
Ostrum Asset Management Investment Advisor 0.0864 2181726 194439 2023-06-30 MED
Newton Investment Management North America, LLC Investment Advisor 0.0838 2116558 -1002724 2023-09-30 MED
Raymond James & Associates, Inc. Research Firm 0.083 2096142 31773 2023-09-30 LOW
Equity Investment Corporation Investment Advisor 0.0772 1948154 -60294 2023-06-30 LOW
BNY Mellon Wealth Management Investment Advisor/Hedge Fund 0.077 1943068 52655 2023-09-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Sanofi Company profile

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The company’s segments are Pharmaceuticals, Human Vaccines, and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the company’s pharmaceuticals operations. The Pharmaceuticals segment also includes all associates whose activities are related to pharmaceuticals. The Vaccines segment is dedicated to vaccines and includes the commercial operations of the company’s vaccines division Sanofi Pasteur and dedicated research and development, production and marketing activities for the company’s vaccines operations. Follow Capital.com to keep up with Sanofi (SNY) share price.
Industry: Pharmaceuticals (NEC)

46 Avenue de la Grande Armée
PARIS
ILE-DE-FRANCE 75017
FR

Income Statement

  • Annual
  • Quarterly

News

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

12:39, 30 November 2023

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023
GBP

UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

10:48, 21 November 2023

People also watch

BTC/USD

38,761.00 Price
+2.540% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

XRP/USD

0.62 Price
+0.910% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

US100

16,001.20 Price
+0.470% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 7.0

Gold

2,072.25 Price
+1.760% 1D Chg, %
Long position overnight fee -0.0193%
Short position overnight fee 0.0111%
Overnight fee time 22:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading